- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05501834
Anxiety Surrounding Supracondylar Pin Removal in Children: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Supracondylar humerus (SCH) fractures are one of the most common pediatric injuries. These fractures are reported as the second most common pediatric fracture, constituting about 18% of all pediatric fractures and approximately 60% of all elbow fractures. The median age of injury is between 3 and 8 years old, peaking at 5 to 6 years old. The gold standard for treating displaced SCH fractures is closed reduction and percutaneous pinning (CRPP); pins are almost always removed three to four weeks post-surgery in outpatient clinics, without anesthesia.
Many would assume that patients experience anxiety during pin removal, but no studies to our knowledge quantified a patient's physiological and behavioral response during this procedure. However, there have been many in-depth investigations of these responses during cast removal procedures, where heart rate (HR) is used as a psychological indicator of anxiety. Additionally, Merkel et al. developed the Face, Legs, Activity, Cry and Consolability (FLACC) Scale which is a valid and reliable tool to quantify pain behaviors in children. Further research showed that the FLACC Scale was also sensitive to painless procedures (i.e. intravenous insertion), and therefore, it can be considered a composite of pain and distress (anxiety).
Anxiety in the medical setting has been linked to future adverse effects for children. Previous publications have shown that patients with anxiety in the perioperative setting have increased postoperative pain, maladaptive behavior, and long-term anxiety with future medical visits. Preoperative anxiety in children also has been reported to have similar negative effects on behavior. It is plausible that an anxiety-provoking procedure, such as pin removal, would have similar effects.
The primary purpose of the first phase of this study (IRB-P00028933), which took place from 2018 to 2020, was to quantify the anxiety experienced by patients undergoing pin removal in clinic following closed reduction and percutaneous pinning (CRPP) for SCH fractures. Now that the first phase is complete, the research team is interested in taking this research another step forward to see how healthcare providers can reduce patient and parent anxiety in clinical settings. Before the first phase of this study, there were no known studies that quantified a patient's physiological and behavioral response during a postoperative pin removal procedure, as CRPP is the gold standard treatment for displaced supracondylar humerus (SCH) fractures. The findings of the primary purpose of the first phase ultimately demonstrated that all patients undergoing pin removal experience an anxiety response, therefore highlighting an area of clinical practice in need of a targeted to help decrease patient anxiety and improve patient experience.
Patients currently proceed with the following clinical flow on the day of their pin removal: (1) patients first present to the cast room for cast removal, (2) radiographs are obtained to confirm alignment and fracture stability, and (3) patients are seen by their provider in an orthopaedic clinic room for pin removal. While this process is streamlined in a busy orthopaedic clinic, it could still take up to an hour of time. After cast removal may also be the first time a patient sees the pins and this added time before pin removal could escalate anxiety. It is evident in the literature that an X-ray prior to pin removal is unnecessary, as it does not change clinical management. Anxiety in the medical setting has been linked to future adverse effects for children, such as increased postoperative pain, maladaptive behavior, and long-term anxiety with future medical visits. It is plausible that an anxiety-provoking procedure, such as pin removal, could have similar effects. Ultimately, the findings of the first phase of our study provide the groundwork for future research efforts in techniques to minimize anxiety for the pediatric patient having to undergo pin removal. Something as simple as changing the clinic flow of our current pin removal process, such as removing pins immediately following cast removal and prior to X-ray, may decrease the overall time waiting for pin removal and decrease patient anxiety.
Therefore, the primary aim of this study is to determine if removing supracondylar pins immediately following cast removal and prior to X-ray decreases patient and parent/guardian anxiety compared to pin removal following cast removal and X-ray. It is hypothesized that patient anxiety response will be lower when pins are removed immediately following cast removal compared to our current standard of care. Secondarily, this study will aim to determine if there is an association between patient anxiety response and their parent's/guardian's anxiety.
After consenting to participate in the trial, patients will be randomized to one of two treatment arms--the intervention or the control-that will be evaluated for this study. We will measure patient and parent/guardian anxiety on the day of pin removal. We plan to randomize patients into two clinical flows: standard of care clinic flow (control treatment) and change in clinic flow (new treatment).
Control Group Patients in the control group will: 1. Go to cast room for cast removal, 2. Go to radiology for X-ray, 3. Will be seen in clinic room for pin removal. These steps are our current standard of care. An orthopedic, cast room technician bivalves and removes the top half of the patient's cast. In radiology, anteroposterior (AP) and lateral X-ray views are obtained to confirm radiographic healing. In the clinic room, a surgeon or nurse removes the pins using pin removal pliers.
Intervention Group Patients in the treatment group will: 1. Go to cast room for cast removal, 2. Have pins immediately pulled after cast removal, 3. Go to radiology for X-ray, 4. Will be seen in clinic room by provider
In both groups, the study coordinator will record FLACC score and HR for patients and STAIS-5 score for parents/guardian. Training to administer the FLACC will include discussion led by the PI (Yi-Meng Yen, MD, PhD) about the 5 categories, clarification of defining characteristics for behaviors, and scoring techniques. Additionally, the study coordinator has already been trained to administer the FLACC and can also teach other study coordinators. If multiple study coordinators are used to administer the FLACC, reliability will be assessed.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Shannon McGurty, BS
- Phone Number: 617-919-4209
- Email: shannon.mcgurty@childrens.harvard.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients aged 3 to ≤8 years at time of surgery
- Supracondylar humerus fractures that are laterally pinned at Boston Children's Hospital
- Scheduled visit for pin removal at either Boston or Waltham orthopedic clinic by a study-participating physician
- English speaking
Exclusion Criteria:
- Patient diagnosed with autism
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
Both arms will receive the same Standard of Care procedures but will receive them in a different order.
Patients in the control group will: 1. Go to cast room for cast removal, 2. Go to radiology for X-ray, 3. Will be seen in clinic room for pin removal.
These steps are our current standard of care.
An orthopedic, cast room technician bivalves and removes the top half of the patient's cast.
In radiology, anteroposterior (AP) and lateral X-ray views are obtained to confirm radiographic healing.
In the clinic room, a surgeon or nurse removes the pins using pin removal pliers.
The order of these procedures is the current Standard of Care.
|
|
|
Experimental: Intervention Group
Both arms will receive the same Standard of Care procedures but will receive them in a different order.
Patients in the treatment group will: 1. Go to cast room for cast removal, 2. Have pins immediately pulled after cast removal, 3. Go to radiology for X-ray, 4. Will be seen in clinic room by provider.
|
Patients in the treatment group will: 1. Go to cast room for cast removal, 2. Have pins immediately pulled after cast removal, 3. Go to radiology for X-ray, 4. Will be seen in clinic room by provider.
The order of these steps differs from our current standard of care, during which patients' pins are removed following cast removal and x-ray imaging.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Face, Legs, Activity, Cry and Consolability (FLACC) scale
Time Frame: During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
The Face, Legs, Activity, Cry and Consolability scale is validated in both young, non-verbal children and older, verbal children.
The FLACC scale measures a patient's response to pain or distress using assessments of (1) facial expression, (2) leg movement, (3) activity, (4) extent to which they cried, and (5) extent to which they are consoled on a scale from 0 to 2 to generate a total score ranging from 0 (no pain/distress) to 10 (maximum pain/distress), with a higher score representing higher rates of anxiety and stress.
|
During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
|
Heart rate
Time Frame: During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
Heart rate will be measured using a pulse oximetry heart rate monitor.
We plan to use heart rate as a physiological correlate to the FLACC scale.
For the purposes of this study, we will define an anxiety response as any patient who scores greater than 0 on the FLACC or achieves a HR in excess of the upper 95% normative limits for their age, sex and race (where applicable).
|
During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Face, Legs, Activity, Cry and Consolability (FLACC) scale
Time Frame: During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
The Face, Legs, Activity, Cry and Consolability scale is validated in both young, non-verbal children and older, verbal children.
The FLACC scale measures a patient's response to pain or distress using assessments of (1) facial expression, (2) leg movement, (3) activity, (4) extent to which they cried, and (5) extent to which they are consoled on a scale from 0 to 2 to generate a total score ranging from 0 (no pain/distress) to 10 (maximum pain/distress), with a higher score representing higher rates of anxiety and stress.
|
During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
|
Heart rate
Time Frame: During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
Heart rate will be measured using a pulse oximetry heart rate monitor.
We plan to use heart rate as a physiological correlate to the FLACC scale.
For the purposes of this study, we will define an anxiety response as any patient who scores greater than 0 on the FLACC or achieves a HR in excess of the upper 95% normative limits for their age, sex and race (where applicable).
|
During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
|
Spielberger State-Trait Anxiety Inventory (STAI-5)
Time Frame: During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
The Spielberger State-Trait Anxiety Inventory (STAI-5) has been widely used to measure the state and trait components of anxiety.
The STAI has been shown to have excellent psychometric properties with good reliability and validity.
The questionnaire can measure anxiety both in healthy and in clinical populations, with those scoring higher on STAI scales indicating to be more prone to experience anxiety.
We plan to use this to measure the parent/guardian anxiety response to patient pin removal.
|
During Treatment (Pin Removal Visit post closed reduction and percutaneous pinning)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yi-Meng Yen, MD, PhD, Boston Children's Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-P00039559
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
Clinical Trials on Supracondylar Pin Removal Before Imaging
-
Ankara Etlik City HospitalActive, not recruitingKnee Osteoarthritis (Knee OA) | Postoperative Hematoma | Total Knee AnthroplastyTurkey (Türkiye)
-
The Dental Hospital of Zhejiang University School...RecruitingPeri-Implantitis | DiagnosisChina
-
Medway NHS Foundation TrustUnknownUrinary RetentionUnited Kingdom
-
First Affiliated Hospital of Chongqing Medical...Unknown
-
Clinique Sainte ClotildeRecruitingProstate Cancer (Adenocarcinoma)Reunion
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceCompleted
-
Luzerner KantonsspitalCompletedInfection Rates Between Primary Wound-closure (Allgower) and Secondary Wound Healing After Removal of an External FixatorSwitzerland
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Basel, Switzerland; Cardiocentro Ticino; Triemli HospitalRecruiting
-
Institut National de la Santé Et de la Recherche...RecruitingHealthy AgingFrance
-
M.D. Anderson Cancer CenterRecruitingBrain LesionUnited States